The Middle East and Africa nasal delivery devices market is expected to reach US$ 5,711.89 million in 2027 from US$ 4,094.32 million in 2019. The market is estimated to grow with a CAGR of 4.3% from 2020 to 2027.
The growth of the market is attributed to driving factors such as increasing government initiatives, growing public awareness, and rising non-communicable diseases and respiratory disorders. However, the market growth is hindered owing to the limitations regarding nasal delivery medications.
Drug delivery systems are technologies primarily used for controlled or targeted delivery of therapeutic agents to treat diseases or improve the health of patients. Nasal drug delivery is an efficient route of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and a superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza. Moreover, this route is suitable for sedation and for treating drug addiction.
Various factors promoting the growth of the healthcare industry include aging population and increasing income and affordability, and high unmet clinical needs. The Saudi market for medical devices is projected at almost US$ 2 billion and is growing annually by ~10%. Greater awareness of health issues and increasing adoption of healthcare services drive the market for medical equipment. The Government of Saudi Arabia is promoting and offering several incentives for domestic manufacturing of medical devices. Moreover, the government and other organizations are conducting conferences and research studies symposiums on nasal delivery systems. For instance, in January 2019, the Department of Pharmacology and Toxicology at Qassim University in Saudi Arabia published a review report on “Nasal Drug Delivery System and Its Contribution in Therapeutic Management.” According to the International Journal of Medicine in Developing Countries 2020 report, nasal decongestants are considered as one of the most commonly available over-the-counter medications in Saudi Arabia. It is advised that nasal decongestants should be only available on a prescription basis. Health workers and advocates are recommended to improve patient awareness related to nasal decongestants of the Saudi population. Thus, an increase in public awareness, serious respiratory diseases, and government initiatives will, in turn, increase the development of new product launches, which are expected to fuel the growth of the nasal delivery devices market.
The COVID-19 pandemic has become the most significant challenge in the region. This challenge is especially frightening for the region’s fragile and conflict-torn states—such as Iraq (416,802), Sudan (13,691), Iran (517,835), Israel (300,201), and Yemen (2,053) confirmed cases, as it leads to reduction of imports due to disruptions in global trade. This further increases the shortages of medical supplies and other goods, resulting in a considerable price hike. The Middle Eastern countries have registered a growth in the number of COVID-19 cases in the last few months, with the UAE registering 111,437 Saudi Arabia reporting 341,062, and South Africa indicating 698,184 confirmed cases. The countries are focusing on the treatment of COVID-19 patients and are looking for a better drug delivery solution in the vaccine development. The impact of the COVID-19 pandemic on regional nasal delivery devices market is moderate.
Based on drug type, the nasal delivery devices market is segmented into anaesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. The antihistamines segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period.
Based on delivery technologies, the nasal delivery devices market is segmented into spray, nebulizers, inhalers, and others. The inhalers segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period.
Based on end user, the nasal delivery devices market is segmented into home care settings, hospitals, and clinics. The home care settings segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period.
International Journal of Medicine in Developing Countries and Bank Melli Iran (BMI) are among the major primary and secondary sources referred to while preparing the report on the Middle East and Africa nasal delivery devices market.